Why we are focusing on diseases that cause severe pain. JanOne a Biotechnology Company
At JanOne, our focus is to treat diseases that cause severe pain at the source and, in the process, we hope to bring non-addictive answers to the market to treat pain. We are starting with Peripheral Artery Disease (PAD), a condition that affects over 8.5 million Americans, many of whom are at risk for addiction when opioids are prescribed to treat the associated pain. JanOne – a biotechnology company.
If we can treat diseases that cause severe pain at the source, we believe we can do our part to reduce opioid addiction at the prescription pad. Learn more about JanOne